1 asset in Small Intestinal Bacterial Overgrowth

Therapeutic assets addressing Small Intestinal Bacterial Overgrowth, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Rifaximin Small Intestinal Bacterial Overgrowth	I.M. Sechenov First Moscow State Medical University	P3	BB (66)